TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8250105

Group type: EXPERIMENTAL
Intervention: Ivermectin (12 mg)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Albendazole (400 mg)
Number of subjects: 21
Study: 3540871

Group type: EXPERIMENTAL
Intervention: naproxen sodium 550 mg
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: codeine sulfate 60 mg
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: naproxen sodium 550 mg with codeine sulfate 60 mg
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: aspirin 650 mg
Number of subjects: 198

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: codeine-containing treatments
Number of subjects: 198
Study: 29914432

Group type: EXPERIMENTAL
Intervention: Maternal schizotypal personality disorder symptoms
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Maternal borderline personality disorder symptoms
Number of subjects: 112
Study: 27494629

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT) applied to one painful finger in 3 sessions with one-week intervals.
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control finger (untreated)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT) applied to one painful finger.
Number of subjects: 4
Study: 24997351

Group type: EXPERIMENTAL
Intervention: Stress (ice cold water)
Number of subjects: 120

Group type: COMPARATOR
Intervention: No stress (warm water)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Stressed female ADRA2B deletion carriers
Number of subjects: 120
Study: 22162577

Group type: EXPERIMENTAL
Intervention: Low-dose tamoxifen
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Fenretinide
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Both agents (low-dose tamoxifen and fenretinide)
Number of subjects: 235

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 235
Study: 21171297

Group type: EXPERIMENTAL
Intervention: Nasal spray specific immunotherapy
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Sublingual specific immunotherapy
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (healthy adults)
Number of subjects: 36
Study: 18539093

Group type: EXPERIMENTAL
Intervention: 400 mg of vaginal misoprostol
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 15640254

Group type: EXPERIMENTAL
Intervention: Laparoscopic electrocautery followed by clomiphene citrate (CC)
Number of subjects: 83
Study: 12910374

Group type: EXPERIMENTAL
Intervention: Epoetin beta 10,000 IE subcutaneously three times a week
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (no epoetin)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Epoetin beta
Number of subjects: 60
Study: 9613780

Group type: EXPERIMENTAL
Intervention: Allogeneic transplantation
Number of subjects: 42

Group type: COMPARATOR
Intervention: Autologous transplantation
Number of subjects: 42
Study: 7914962

Group type: EXPERIMENTAL
Intervention: ursodeoxycholic acid plus norfloxacin (13‐15 mg/kg and 400 mg, daily)
Number of subjects: 20
Study: 2847465

Group type: EXPERIMENTAL
Intervention: 120 U(anti-FXa)/kg Fragmin injected twice daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: 240 U/kg, 12 h standard heparin as continuous infusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fragmin
Number of subjects: 0
Study: 30604337

Group type: EXPERIMENTAL
Intervention: Intermittent galvanic stimulation to bilateral masseter muscles for 5 days/week, for 4 weeks combined with conventional dysphagia rehabilitation
Number of subjects: 102

Group type: COMPARATOR
Intervention: Sham stimulation with conventional dysphagia rehabilitation
Number of subjects: 102
Study: 29656504

Group type: EXPERIMENTAL
Intervention: MYL‐1501D
Number of subjects: 558

Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 558

Group type: COMPARATOR
Intervention: MYL‐1501D and Insulin glargine
Number of subjects: 558
Study: 28886751

Group type: EXPERIMENTAL
Intervention: Uva-ursi + advice to take ibuprofen
Number of subjects: 328

Group type: COMPARATOR
Intervention: Placebo + advice to take ibuprofen
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Uva-ursi + no advice to take ibuprofen
Number of subjects: 328

Group type: COMPARATOR
Intervention: Placebo + no advice to take ibuprofen
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 328
Study: 26336731

Group type: EXPERIMENTAL
Intervention: Total broncho-alveolar lavage
Number of subjects: 0
Study: 24101768

Group type: EXPERIMENTAL
Intervention: High altitude treatment (≥ 2000 m)
Number of subjects: 958

Group type: COMPARATOR
Intervention: Low altitude treatment (<2000 m)
Number of subjects: 958
Study: 21390432

Group type: EXPERIMENTAL
Intervention: Incentive Spirometry (IS)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Breath Stacking (BS)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Exercise Control (EC)
Number of subjects: 35
Study: 18460557

Group type: EXPERIMENTAL
Intervention: COM (MET 1000 mg BID, EX 10 microg BID)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: EX (10 microg BID)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: MET (1000 mg BID)
Number of subjects: 60
Study: 16434984

Group type: EXPERIMENTAL
Intervention: IL-2 alone
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: IL-2/HDC
Number of subjects: 63
Study: 12946090

Group type: EXPERIMENTAL
Intervention: Low intensity 12-month intervention
Number of subjects: 386
Study: 11078770

Group type: EXPERIMENTAL
Intervention: Atovaquone (750 mg every 12 hours) and azithromycin (500 mg on day 1 and 250 mg per day thereafter) for seven days
Number of subjects: 58

Group type: COMPARATOR
Intervention: Clindamycin (600 mg every 8 hours) and quinine (650 mg every 8 hours) for seven days
Number of subjects: 58
Study: 9329303

Group type: EXPERIMENTAL
Intervention: Vitamin A treatment (200,000 IU for infants, 400,000 IU for 1-4 year olds)
Number of subjects: 472

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 472
Study: 8518642

Group type: EXPERIMENTAL
Intervention: Community mother intervention (monthly visits during the first year)
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Community mother intervention
Number of subjects: 262

Group type: COMPARATOR
Intervention: Standard support from public health nurse (Control)
Number of subjects: 262
Study: 3559811

Group type: EXPERIMENTAL
Intervention: Inositol supplementation (40 mg/kg every 6 hours)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Inositol supplementation
Number of subjects: 48
Study: 29920085

Group type: EXPERIMENTAL
Intervention: Consumption of pulses (white beans, chickpeas, and lentils)
Number of subjects: 11
Study: 27048275

Group type: EXPERIMENTAL
Intervention: Conventional NiTi archwires
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Copper NiTi (NiTiCu) archwires
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Epoxy-coated NiTi archwires
Number of subjects: 42
Study: 26578039

Group type: EXPERIMENTAL
Intervention: Corneal confocal microscopy (CCM)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Intraepidermal nerve fiber density (IENFD)
Number of subjects: 26
Study: 23401478

Group type: EXPERIMENTAL
Intervention: Training that reinforces the association between Blacks and danger (Experiment 2a and 2b)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Training that eliminates bias by focusing on diagnostic object information (gun vs. no gun)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reading about Black criminals (Experiment 1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reading about White criminals (Experiment 1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Expert training and police officer experience
Number of subjects: 0
Study: 21541451

Group type: EXPERIMENTAL
Intervention: Aerobic training during hemodialysis, performed for 12 weeks, three times weekly.
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Aerobic training during hemodialysis for 12 weeks.
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (no aerobic training).
Number of subjects: 22
Study: 19065902

Group type: EXPERIMENTAL
Intervention: Propyl gallate (PrG) in combination with standard medication
Number of subjects: 55

Group type: COMPARATOR
Intervention: Salvia composite (SC) in combination with standard medication
Number of subjects: 55
Study: 16898901

Group type: EXPERIMENTAL
Intervention: Drug exposure (provocation tests)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo exposure (provocation tests)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Overall psychological reactions during testing
Number of subjects: 10
Study: 12860964

Group type: EXPERIMENTAL
Intervention: Cisplatin 75 mg/m2 plus a 24-hour infusion of paclitaxel 135 mg/m2 (arm I)
Number of subjects: 792

Group type: COMPARATOR
Intervention: Carboplatin area under the curve 7.5 intravenously plus paclitaxel 175 mg/m2 over 3 hours (arm II)
Number of subjects: 792
Study: 10026402

Group type: EXPERIMENTAL
Intervention: Melatonin (N‐acetyl‐5‐methoxytryptamine) applied after UVR exposure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin E (alpha‐tocopherol) applied after UVR exposure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin C (ascorbic acid) applied after UVR exposure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of antioxidants applied after UVR exposure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple applications of antioxidants (three times: 30 min, 1 h and 2 h after irradiation)
Number of subjects: 0
Study: 9048259

Group type: EXPERIMENTAL
Intervention: Monounsaturate-rich butter and cheese (B)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Normal butter and cheese (A)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Polyunsaturate-rich spread and cheese (C)
Number of subjects: 30
Study: 1649725

Group type: EXPERIMENTAL
Intervention: Lithium carbonate 300 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Lithium carbonate 600 mg
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 6983719

Group type: EXPERIMENTAL
Intervention: Electrical spinal cord stimulation
Number of subjects: 11
Study: 30353121

Group type: EXPERIMENTAL
Intervention: L-carnitine supplementation (1,000 mg injections 3 times per week after each hemodialysis session)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group (no injections)
Number of subjects: 91
Study: 29861021

Group type: EXPERIMENTAL
Intervention: RR+RR (same passage seven times)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: RR+Guided Wide Reading (one passage four times and three passages each once)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: GWR+GWR (seven passages each once)
Number of subjects: 130
Study: 27428608

Group type: EXPERIMENTAL
Intervention: Monsel solution
Number of subjects: 145
Study: 24974996

Group type: EXPERIMENTAL
Intervention: If-then planning
Number of subjects: 14

Group type: COMPARATOR
Intervention: Routine clinical instructions
Number of subjects: 14
Study: 21252144

Group type: EXPERIMENTAL
Intervention: LPA genotype score
Number of subjects: 12236
Study: 18250225

Group type: EXPERIMENTAL
Intervention: Closed tracheal suction systems (TSS)
Number of subjects: 9
Study: 16093520

Group type: EXPERIMENTAL
Intervention: High levels of posttraumatic stress (PTS) or depressive symptoms and/or high preinjury alcohol use
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adolescent female gender, greater levels of preinjury trauma, greater subjective distress at the time of the injury, and greater parental depressive symptoms
Number of subjects: 0
Study: 12548293

Group type: COMPARATOR
Intervention: Maltitol (occasional consumption)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sucrose (occasional consumption)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Maltitol (regular consumption)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sucrose (regular consumption)
Number of subjects: 12
Study: 11199620

Group type: EXPERIMENTAL
Intervention: Acupuncture at the P‐6 Neikuan point
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thumb pressure at the P‐6 point
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: P‐6 point stimulation
Number of subjects: 0
Study: 8839823

Group type: EXPERIMENTAL
Intervention: Predictive mode (PRD) with step‐ramp stimulus at 12.5 to 50 degrees/s, target exposure durations (PD) from 80 to 640 ms, passive stimulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonpredictive mode (RND) with randomized direction and timing of target exposure, active and passive stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Predictive mode (PRD)
Number of subjects: 0
Study: 1394825

Group type: EXPERIMENTAL
Intervention: CMV regimen (cisplatin, methotrexate, and vinblastine)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: M-VAC regimen (methotrexate, vinblastine, doxorubicin, and cisplatin)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Toxic symptoms in both groups
Number of subjects: 19
Study: 4001759

Group type: EXPERIMENTAL
Intervention: Flunisolide nasal spray 0.025% (2 X 25 mcg in each nostril twice daily)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 31976769

Group type: EXPERIMENTAL
Intervention: Virtual simulation engagement
Number of subjects: 123

Group type: COMPARATOR
Intervention: Observation of simulation engagement
Number of subjects: 123

Group type: COMPARATOR
Intervention: Reading text vignettes
Number of subjects: 123
Study: 30621529

Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS)
Number of subjects: 4754

Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 4754

Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS) in patients aged ≥75 with CHD
Number of subjects: 4754

Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS) in patients aged <70 with CHD
Number of subjects: 4754

Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS) in patients aged 70 to 74 with CHD
Number of subjects: 4754

Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS) in patients aged 70 to 74 without CHD
Number of subjects: 4754

Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS) in patients aged ≥75 without CHD
Number of subjects: 4754

Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS) in patients aged <70 without CHD
Number of subjects: 4754
Study: 29231472

Group type: EXPERIMENTAL
Intervention: Acupuncture with smoothing liver and regulating qi, once a day for 6 weeks.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Lactulose oral liquid, 20 to 30 mL once a day for 6 weeks.
Number of subjects: 60
Study: 25491935

Group type: EXPERIMENTAL
Intervention: 12 weeks of supervised aerobic exercise
Number of subjects: 122

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Control group without crossover
Number of subjects: 122

Group type: COMPARATOR
Intervention: Control group with crossover
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Exercise group with <80% adherence
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Exercise group with ≥80% adherence
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Supervised exercise groups (combined)
Number of subjects: 122

Group type: COMPARATOR
Intervention: No supervised exercise (control)
Number of subjects: 122
Study: 23750468

Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT; Coping Cat)
Number of subjects: 488

Group type: COMPARATOR
Intervention: Pharmacotherapy (sertraline)
Number of subjects: 488

Group type: COMPARATOR
Intervention: Combined treatment (CBT + sertraline)
Number of subjects: 488

Group type: COMPARATOR
Intervention: Placebo pill
Number of subjects: 488
Study: 21276573

Group type: EXPERIMENTAL
Intervention: Overlay Ref
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control
Number of subjects: 88
Study: 19453020

Group type: EXPERIMENTAL
Intervention: Early laparoscopic cholecystectomy (within 72 hours)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Delayed laparoscopic cholecystectomy (after 72 hours)
Number of subjects: 0
Study: 17019522

Group type: EXPERIMENTAL
Intervention: Calcium from milk minerals (MM) 800 mg/day
Number of subjects: 99

Group type: COMPARATOR
Intervention: Calcium carbonate (CC) 800 mg/day
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo (Pla)
Number of subjects: 99
Study: 15242535

Group type: EXPERIMENTAL
Intervention: Single-dose nevirapine (NVP) prophylaxis
Number of subjects: 279
Study: 10768912

Group type: EXPERIMENTAL
Intervention: ACE inhibitors (group A)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: No ACE inhibitors (group B)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: ACE inhibitors (group A) and No ACE inhibitors (group B)
Number of subjects: 41
Study: 10168910

Group type: EXPERIMENTAL
Intervention: Wearable augmented reality medical interfaces (WARM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interface objects for display of real-time electrocardiographic monitoring information
Number of subjects: 0
Study: 8465450

Group type: EXPERIMENTAL
Intervention: Occupational therapy three times a week for three weeks
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression for twenty minutes before occupational therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (twenty-three patients)
Number of subjects: 40
Study: 3080048

Group type: EXPERIMENTAL
Intervention: Antivenom given by intravenous injection over 10 minutes
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Antivenom diluted and given as an intravenous infusion over 30 minutes
Number of subjects: 25

Group type: COMPARATOR
Intervention: Antivenom treatment (both methods)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Higher doses of antivenom (not specifically tested in this trial)
Number of subjects: 25
Study: 30236067

Group type: EXPERIMENTAL
Intervention: Pen-and-paper response option (Group A)
Number of subjects: 2606

Group type: EXPERIMENTAL
Intervention: Mixed response option (Group B)
Number of subjects: 2606

Group type: COMPARATOR
Intervention: Electronic response option (Group C)
Number of subjects: 2606

Group type: EXPERIMENTAL
Intervention: Mixed group (Group B)
Number of subjects: 2606
Study: 27308241

Group type: EXPERIMENTAL
Intervention: Steri-strip dressing applied from the nose to lateral malar and cheek
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control side with steri-strip taping from the nose to medial malar and cheek
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Steri-strip dressing
Number of subjects: 64
Study: 24268111

Group type: EXPERIMENTAL
Intervention: Pregabalin 252 mg
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 13
Study: 22717019

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Interpersonal Psychotherapy (IPT)
Number of subjects: 91
Study: 20501391

Group type: EXPERIMENTAL
Intervention: Etomidate infusion
Number of subjects: 40

Group type: COMPARATOR
Intervention: Propofol infusion
Number of subjects: 40
Study: 18656731

Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 16635321

Group type: EXPERIMENTAL
Intervention: Routine early amniotomy
Number of subjects: 0
Study: 12971557

Group type: EXPERIMENTAL
Intervention: Microscopy
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: On-site OptiMAL
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: On-site Immunochromatographic Test (on-site ICT)
Number of subjects: 436
Study: 10836011

Group type: EXPERIMENTAL
Intervention: Neoadjuvant therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adjuvant postoperative radiation or chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Multimodal approach
Number of subjects: 0
Study: 9369817

Group type: EXPERIMENTAL
Intervention: Controlled cord traction
Number of subjects: 1648

Group type: COMPARATOR
Intervention: Minimal intervention
Number of subjects: 1648
Study: 1410069

Group type: EXPERIMENTAL
Intervention: d‐l fenfluramine hydrochloride (60 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 3882183

Group type: EXPERIMENTAL
Intervention: Oral 5-fluorouracil (5 mg kg‐1 bodyweight) for 3 months
Number of subjects: 421

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 421
Study: 30946967

Group type: EXPERIMENTAL
Intervention: Black Strap Molasses (BSM) syrup (1 mL/kg body weight/day for 1 month)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Polyethylene Glycol (PEG) syrup (1 mL/kg body weight/day for 1 month)
Number of subjects: 92
Study: 28672136

Group type: EXPERIMENTAL
Intervention: Propofol alone (P group)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Combination of propofol and midazolam (PM group)
Number of subjects: 27
Study: 27240438

Group type: EXPERIMENTAL
Intervention: Renal sympathetic denervation (RSD)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control (antiarrhythmic pharmacologic therapy)
Number of subjects: 34
Study: 24833688

Group type: EXPERIMENTAL
Intervention: High absolute risk patients with high blood pressure (SBP 147-179 mm Hg)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Lower absolute risk patients with high blood pressure
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Lower blood pressure patients with high absolute risk
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Lower blood pressure patients with lower absolute risk
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: High cholesterol/high absolute risk patients
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: High cholesterol/lower absolute risk patients
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Lower cholesterol patients with high absolute risk
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Lower cholesterol patients with lower absolute risk
Number of subjects: 144
Study: 22476736

Group type: EXPERIMENTAL
Intervention: Gum chewing (3 times a day from postoperative day 0-5)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Standard postoperative care (Control group)
Number of subjects: 44